FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product

[ad_1] The FDA has approved Moderna’s RSV vaccine for older adults. Courtesy: Moderna The Food and…

Pfizer’s drug for advanced lung cancer shows promising long-term trial results

[ad_1] CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer…

AI cancer screening programs are booming, but you’ll likely have to pay for them yourself

[ad_1] Artificial intelligence for cancer screening has taken off. Yet most of those new programs aren’t…

Why half of all workers may struggle to get weight-loss drug health insurance coverage

[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…

Nutritional needs are ‘shifting’ amid rise of weight loss drugs, says Nestle CEO

[ad_1] The meteoric rise of weight loss drugs means consumers’ nutritional needs are “shifting” which provides…

Why Walmart, Walgreens, CVS retail health clinic experiment is struggling

[ad_1] Bobbi Radford showed up at the CVS MinuteClinic in Batavia, Ohio, last Thanksgiving because she had pain…

Here’s how U.S. health officials are responding to bird flu in humans after second case

[ad_1] Cows are seen standing in a feedlot on June 14, 2023 in Quemado, Texas. Brandon…

Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply

[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…

Two CVS retail stores in Rhode Island join new national pharmacy union

[ad_1] The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store…

Eli Lilly’s big GLP-1 investment — plus, what we want from 4 portfolio stock earnings

[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at…

This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A

[ad_1] Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class…

A corner of the cancer therapy market is heating up—Here are the names investors need to know

[ad_1] There’s been a lot of attention lately on a corner of the oncology market called…

Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts

[ad_1] Exterior view of the Pfizer headquarters building in New York City on Jan. 29, 2023.…

New Covid FLiRT variants spark concerns of a summer spike

[ad_1] Woman wearing face masksto protect against Covid-19 on 7th April 2024 in London, United Kingdom.…

We’re encouraged by an activist’s willingness to buy an Abbott rival, look past baby formula suits

[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable…

Newseum Global